Discover the detailed record of transactions filed by REED ELIZABETH E, General Secretary. Officer active across 1 companies, notably Travere Therapeutics, Inc.. Aggregated, 11 disclosures have been published. Total volume traded: €169k. The latest transaction was filed on 10 May 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Elizabeth E. Reed is the Senior Vice President, General Counsel, and Corporate Secretary of Travere Therapeutics, Inc. She oversees the company's legal affairs and compliance. Her role is essential for ensuring legal protection and compliance.